Changes in BNP levels from discharge to 6-month visit predict subsequent outcomes in patients with acute heart failure.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
03
11
2021
accepted:
12
01
2022
entrez:
28
1
2022
pubmed:
29
1
2022
medline:
23
2
2022
Statut:
epublish
Résumé
This study aimed to investigate the association between changes in brain natriuretic peptide (BNP) from discharge to 6-month visit and subsequent clinical outcomes in patients with acute heart failure (AHF). Among 1246 patients enrolled in the prospective longitudinal follow-up study nested from the Kyoto Congestive Heart Failure registry, this study population included 446 patients with available paired BNP data at discharge and 6-month index visit. This study population was classified into 3 groups by percent change in BNP from discharge to 6-month visit; the low tertile (≤-44%, N = 149), the middle tertile (>-44% and ≤22%, N = 149) and the high tertile (>22%, N = 148). The cumulative 180-day incidence after the index visit of the primary outcome measure (a composite endpoint of all-cause death or hospitalization for HF) was significantly higher in the high and middle tertiles than in the low tertile (26.8% and 14.4% versus 6.9%, log-rank P<0.0001). The adjusted excess risk of the high tertile relative to the low tertile remained significant for the primary outcome measure (hazard ratio: 3.43, 95% confidence interval: 1.51-8.46, P = 0.003). Percent change in BNP was associated with a subsequent risk for a composite of all-cause death and hospitalization for HF after adjustment of the absolute BNP values, suggesting that observing the change in BNP levels, in addition to absolute BNP levels themselves, helps us to manage patient with HF.
Sections du résumé
BACKGROUND
This study aimed to investigate the association between changes in brain natriuretic peptide (BNP) from discharge to 6-month visit and subsequent clinical outcomes in patients with acute heart failure (AHF).
METHODS
Among 1246 patients enrolled in the prospective longitudinal follow-up study nested from the Kyoto Congestive Heart Failure registry, this study population included 446 patients with available paired BNP data at discharge and 6-month index visit. This study population was classified into 3 groups by percent change in BNP from discharge to 6-month visit; the low tertile (≤-44%, N = 149), the middle tertile (>-44% and ≤22%, N = 149) and the high tertile (>22%, N = 148).
FINDINGS
The cumulative 180-day incidence after the index visit of the primary outcome measure (a composite endpoint of all-cause death or hospitalization for HF) was significantly higher in the high and middle tertiles than in the low tertile (26.8% and 14.4% versus 6.9%, log-rank P<0.0001). The adjusted excess risk of the high tertile relative to the low tertile remained significant for the primary outcome measure (hazard ratio: 3.43, 95% confidence interval: 1.51-8.46, P = 0.003).
CONCLUSIONS
Percent change in BNP was associated with a subsequent risk for a composite of all-cause death and hospitalization for HF after adjustment of the absolute BNP values, suggesting that observing the change in BNP levels, in addition to absolute BNP levels themselves, helps us to manage patient with HF.
Identifiants
pubmed: 35089974
doi: 10.1371/journal.pone.0263165
pii: PONE-D-21-35110
pmc: PMC8797237
doi:
Substances chimiques
Natriuretic Peptide, Brain
114471-18-0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0263165Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Clin Chim Acta. 2013 Sep 23;424:287-91
pubmed: 23850775
Eur J Heart Fail. 2008 Sep;10(9):824-39
pubmed: 18760965
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
ESC Heart Fail. 2017 Aug;4(3):216-223
pubmed: 28772047
Am Heart J. 1998 May;135(5 Pt 1):825-32
pubmed: 9588412
Eur J Heart Fail. 2005 Oct;7(6):1040-8
pubmed: 16227142
J Card Fail. 2019 Sep;25(9):712-721
pubmed: 30965102
J Cardiol. 2018 May;71(5):505-512
pubmed: 29183646
BMC Cardiovasc Disord. 2017 Aug 3;17(1):215
pubmed: 28774268
J Clin Invest. 1991 Apr;87(4):1402-12
pubmed: 1849149
Int J Cardiol. 2014 Oct 20;176(3):611-7
pubmed: 25156856
BMJ. 2015 Mar 04;350:h910
pubmed: 25740799
Circ J. 2018 Oct 25;82(11):2811-2819
pubmed: 30259898
Am J Cardiol. 2018 Mar 15;121(6):731-738
pubmed: 29394996
Circulation. 2005 Dec 20;112(25):3958-68
pubmed: 16365214
Am J Cardiol. 2017 Jan 1;119(1):71-77
pubmed: 27776801
Int J Cardiol. 2018 Oct 15;269:196-200
pubmed: 30001941
Eur Heart J. 2020 Nov 1;41(41):4050-4056
pubmed: 32077940
J Am Coll Emerg Physicians Open. 2021 Jun 18;2(3):e12448
pubmed: 34179876
J Card Fail. 2019 Sep;25(9):703-711
pubmed: 30953792
Clin Chim Acta. 2015 Mar 30;443:17-24
pubmed: 24937843
Circ J. 2019 Sep 25;83(10):2084-2184
pubmed: 31511439
J Am Coll Cardiol. 2016 Dec 6;68(22):2425-2436
pubmed: 27908347
Heart. 2019 Aug;105(15):1182-1189
pubmed: 30962192
Sci Rep. 2018 Apr 23;8(1):6366
pubmed: 29686287